Ab
heterophil antibody
ozogamicin
-o-
vobarilizumab
heterophile antibody
immunotarget
hyperimmunoglobulin
muromonab
immunoturbidometric
tucotuzumab
lenzilumab
leronlimab
agonistic monoclonal antibody
sonepcizumab
serospecific
anticorrelate
seroimmunity
elotuzumab
immunoepidemiological
immunofluorographic
immunodeposit
immunoabsorptive
immunochemical
mapatumumab
immunoreacting
mepolizumab
glembatumumab
casirivimab
antimonoclonal
immunoprobe
sotrovimab
immunoprophylactic
tislelizumab
immunoepidemiology
gevokizumab
drozitumab
immunoresistant
immunoassayable
immunopotentiative
olaratumab
ravulizumab
pidilizumab
brolucizumab
abagovomab
immunoconvert
immunofluorohistochemical
briakinumab
IgM